SkinHealth receives Nasdaq deficiency notice for bid price below $1.00

SkinHealth Systems Inc.

• Received Nasdaq notice on May 8, 2026; closing bid price below $1.00 for 30 consecutive business days through May 7.
• Must regain compliance by Nov 4, 2026; need closing bid price ≥ $1.00 for at least 10 consecutive trading days.
• May qualify for additional 180-day cure period if met other listing standards and notifies Nasdaq of cure plan.
• Company evaluating options including reverse stock split to address deficiency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.